SOMATROPIN
somatropin 5 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber],
1 dual chamber pen device
SOMATROPIN (11493X)
11493X
Manner of administration:Injection
Restriction
Indication: Severe growth hormone deficiency
Treatment phase: Initial treatment of late onset growth hormone deficiency
Restriction
Indication: Severe growth hormone deficiency
Treatment phase: Continuing treatment in a person with a mature skeleton or aged 18 years or older
Restriction
Indication: Severe growth hormone deficiency
Treatment phase: Initial treatment of childhood onset growth hormone deficiency in a patient who has
received PBS-subsidised treatment as a child
Restriction
Indication: Severe growth hormone deficiency
Treatment phase: Initial treatment of childhood onset growth hormone deficiency in a patient who has
received non-PBS subsidised treatment as a child
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 5 | DPMQ: $166.45 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Genotropin GoQuick | |||||